Dr. Cryns is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
451 Junction Rd
Madison, WI 53717Phone+1 608-263-5010Fax+1 608-263-9983
Summary
- Dr. Cryns is Professor of Medicine and Chief of the Division of Endocrinology, Diabetes and Metabolism at the University of Wisconsin-Madison School of Medicine and Public Health. He leads a multidisciplinary team of scientists who focus on understanding how cells die. His group is especially interested in elucidating how abnormalities in cell death contribute to the pathogenesis of cancer and other diseases and in translating these insights into improved biomarkers and pro-apoptotic therapies.
Education & Training
- Massachusetts General HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 1990 - 1993
- Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalResidency, Internal Medicine, 1988 - 1990
- Massachusetts General HospitalInternship, Internal Medicine, 1987 - 1988
- Harvard Medical SchoolClass of 1987
Certifications & Licensure
- WI State Medical License 2011 - 2025
- IL State Medical License 1997 - 2014
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Best Doctors in America 2013-2014
- Elected Member American Society for Clinical Investigation (ASCI), 2005
Clinical Trials
- A Window of Opportunity Study of Methionine Deprivation in Triple Negative Breast Cancer Start of enrollment: 2017 Aug 10
- ONC201 With a Methionine-Restricted Diet in Patients With Metastatic Triple Negative Breast Cancer Start of enrollment: 2018 Nov 13
Publications & Presentations
PubMed
- 1048 citationsProteases to die forVincent L. Cryns, Junying Yuan
Genes & Development. 1998-06-01 - 4 citationsαB-crystallin and HspB2 deficiency is protective from diet-induced glucose intolerance.Daniel J. Toft, Miles Fuller, Matthew J. Schipma, Feng Chen, Vincent L. Cryns
Genomics Data. 2016-05-13 - 54 citationsGSK-3 inhibition overcomes chemoresistance in human breast cancerAndrey Ugolkov, Irina N. Gaisina, Jin San Zhang, Daniel D. Billadeau, Kevin P. White
Cancer Letters. 2016-10-01
Press Mentions
- UW Madison Scientists Discover Cancer Pathway BreakthroughApril 5th, 2019
- Unlocking a Secret of the Anti-Cancer Gene p53March 18th, 2019
- UW-Madison Scientists Make Key Discovery on Protein That's a Major Focus of Cancer ResearchMarch 18th, 2019
- Join now to see all
External Links
- Cryns labhttp://crynslab.medicine.wisc.edu/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: